Annual Current Assets
$27.40 M
-$18.12 M-39.80%
31 December 2023
Summary:
Theriva Biologics annual total current assets is currently $27.40 million, with the most recent change of -$18.12 million (-39.80%) on 31 December 2023. During the last 3 years, it has risen by +$19.47 million (+245.39%). TOVX annual current assets is now -60.20% below its all-time high of $68.86 million, reached on 31 December 2021.TOVX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$19.53 M
-$182.00 K-0.92%
01 September 2024
Summary:
Theriva Biologics quarterly total current assets is currently $19.53 million, with the most recent change of -$182.00 thousand (-0.92%) on 01 September 2024. Over the past year, it has dropped by -$15.23 million (-43.82%). TOVX quarterly current assets is now -75.16% below its all-time high of $78.64 million, reached on 01 March 2021.TOVX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -39.8% | -43.8% |
3 y3 years | +245.4% | -71.6% |
5 y5 years | +66.8% | +18.9% |
TOVX Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -60.2% | +245.4% | -71.6% | at low |
5 y | 5 years | -60.2% | +245.4% | -75.2% | +193.2% |
alltime | all time | -60.2% | >+9999.0% | -75.2% |
Theriva Biologics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $19.53 M(-0.9%) |
June 2024 | - | $19.71 M(-9.0%) |
Mar 2024 | - | $21.66 M(-21.0%) |
Dec 2023 | $27.82 M(+5.6%) | $27.40 M(-21.2%) |
Sept 2023 | - | $34.77 M(-8.4%) |
June 2023 | - | $37.97 M(-5.8%) |
Mar 2023 | - | $40.30 M(-11.5%) |
Dec 2022 | $26.34 M(+1647.9%) | $45.52 M(-13.7%) |
Sept 2022 | - | $52.73 M(-3.9%) |
June 2022 | - | $54.89 M(-7.8%) |
Mar 2022 | - | $59.55 M(-13.5%) |
Dec 2021 | $1.51 M(+216.6%) | - |
Dec 2021 | - | $68.86 M(-6.4%) |
Sept 2021 | - | $73.56 M(-2.7%) |
June 2021 | - | $75.63 M(-3.8%) |
Mar 2021 | - | $78.64 M(+891.1%) |
Dec 2020 | $476.00 K(-41.2%) | $7.93 M(+19.1%) |
Sept 2020 | - | $6.66 M(-25.6%) |
June 2020 | - | $8.96 M(-19.8%) |
Mar 2020 | - | $11.17 M(-32.0%) |
Dec 2019 | $809.00 K(+28.4%) | $16.43 M(-17.2%) |
Sept 2019 | - | $19.84 M(-13.8%) |
June 2019 | - | $23.01 M(-10.0%) |
Mar 2019 | - | $25.55 M(-13.4%) |
Dec 2018 | $630.00 K(-29.6%) | $29.51 M(+192.0%) |
Sept 2018 | - | $10.11 M(+31.9%) |
June 2018 | - | $7.66 M(-34.2%) |
Mar 2018 | - | $11.64 M(-35.1%) |
Dec 2017 | $895.00 K(-3.6%) | $17.94 M(-19.6%) |
Sept 2017 | - | $22.31 M(+49.6%) |
June 2017 | - | $14.92 M(-11.4%) |
Mar 2017 | - | $16.84 M(-21.9%) |
Dec 2016 | $928.00 K(+82.7%) | $21.57 M(+182.3%) |
Sept 2016 | - | $7.64 M(-51.7%) |
June 2016 | - | $15.82 M(-28.8%) |
Mar 2016 | - | $22.22 M(-26.8%) |
Dec 2015 | $508.00 K(+615.5%) | $30.34 M(-28.0%) |
Sept 2015 | - | $42.14 M(+259.8%) |
June 2015 | - | $11.71 M(-14.0%) |
Mar 2015 | - | $13.62 M(-28.6%) |
Dec 2014 | $71.00 K(+73.2%) | $19.07 M(+308.6%) |
Sept 2014 | - | $4.67 M(-49.4%) |
June 2014 | - | $9.23 M(-26.1%) |
Mar 2014 | - | $12.49 M(-23.0%) |
Dec 2013 | $41.00 K(-95.7%) | $16.22 M(+138.8%) |
Sept 2013 | - | $6.79 M(-28.2%) |
June 2013 | - | $9.46 M(-17.4%) |
Mar 2013 | - | $11.45 M(-8.1%) |
Dec 2012 | $960.00 K(+171.2%) | $12.46 M(+157.0%) |
Sept 2012 | - | $4.85 M(-22.7%) |
June 2012 | - | $6.27 M(-14.4%) |
Mar 2012 | - | $7.33 M(+2.9%) |
Dec 2011 | $354.00 K(-37.5%) | $7.12 M(-12.0%) |
Sept 2011 | - | $8.09 M(-9.1%) |
June 2011 | - | $8.91 M(+35.3%) |
Mar 2011 | - | $6.58 M(+85.7%) |
Dec 2010 | $566.00 K | $3.54 M(-4.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $3.70 M(+7.5%) |
June 2010 | - | $3.44 M(+66.1%) |
Mar 2010 | - | $2.07 M(-24.7%) |
Dec 2009 | $1.32 M(-9.4%) | $2.75 M(-24.7%) |
Sept 2009 | - | $3.66 M(-19.0%) |
June 2009 | - | $4.51 M(-15.7%) |
Mar 2009 | - | $5.36 M(-9.6%) |
Dec 2008 | $1.46 M(-29.8%) | $5.93 M(-8.7%) |
Sept 2008 | - | $6.49 M(-13.6%) |
June 2008 | - | $7.52 M(-15.0%) |
Mar 2008 | - | $8.85 M(-23.5%) |
Dec 2007 | $2.08 M(+598.5%) | $11.56 M(+56.8%) |
Sept 2007 | - | $7.37 M(-19.3%) |
June 2007 | - | $9.13 M(-16.8%) |
Mar 2007 | - | $10.97 M(-10.2%) |
Dec 2006 | $297.30 K(+5.4%) | $12.22 M(>+9900.0%) |
Sept 2006 | - | $0.00(0.0%) |
June 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $282.10 K(-58.5%) | - |
Mar 2003 | - | $574.10 K(-31.3%) |
Dec 2002 | $679.30 K(-0.6%) | $835.30 K(-21.5%) |
Sept 2002 | - | $1.06 M(-32.0%) |
June 2002 | - | $1.56 M(-5.1%) |
Mar 2002 | - | $1.65 M(+20.0%) |
Dec 2001 | $683.40 K(+26.3%) | $1.37 M(-48.0%) |
Sept 2001 | - | $2.64 M(-7.6%) |
June 2001 | - | $2.86 M(-7.3%) |
Mar 2001 | - | $3.08 M(-37.2%) |
Dec 2000 | $541.00 K(+6.2%) | $4.91 M(+67.3%) |
Sept 2000 | - | $2.93 M(-15.3%) |
June 2000 | - | $3.46 M(-40.7%) |
Mar 2000 | - | $5.84 M(+28.7%) |
Dec 1999 | $509.60 K(+94.1%) | $4.54 M(+249.2%) |
Sept 1999 | - | $1.30 M(-18.8%) |
June 1999 | - | $1.60 M(-23.8%) |
Mar 1999 | - | $2.10 M(-19.2%) |
Dec 1998 | $262.50 K(+31.3%) | $2.60 M(-10.3%) |
Sept 1998 | - | $2.90 M(-50.8%) |
June 1998 | - | $5.90 M(+5800.0%) |
Mar 1998 | - | $100.00 K(-80.0%) |
Dec 1997 | $200.00 K(-33.3%) | $500.00 K(-54.5%) |
Sept 1997 | - | $1.10 M(+37.5%) |
June 1997 | - | $800.00 K(-75.8%) |
Mar 1997 | - | $3.30 M(+32.0%) |
Dec 1996 | $300.00 K(+50.0%) | $2.50 M(-41.9%) |
Sept 1996 | - | $4.30 M(-17.3%) |
June 1996 | - | $5.20 M(+147.6%) |
Mar 1996 | - | $2.10 M(+5.0%) |
Dec 1995 | $200.00 K(-33.3%) | $2.00 M(-37.5%) |
Sept 1995 | - | $3.20 M(+3100.0%) |
Dec 1994 | $300.00 K(+200.0%) | $100.00 K(-97.8%) |
Mar 1994 | - | $4.60 M(+170.6%) |
Dec 1993 | $100.00 K | $1.70 M(-41.4%) |
Sept 1993 | - | $2.90 M(-34.1%) |
June 1993 | - | $4.40 M(-12.0%) |
Mar 1993 | - | $5.00 M |
FAQ
- What is Theriva Biologics annual total current assets?
- What is the all time high annual current assets for Theriva Biologics?
- What is Theriva Biologics annual current assets year-on-year change?
- What is Theriva Biologics quarterly total current assets?
- What is the all time high quarterly current assets for Theriva Biologics?
- What is Theriva Biologics quarterly current assets year-on-year change?
What is Theriva Biologics annual total current assets?
The current annual current assets of TOVX is $27.40 M
What is the all time high annual current assets for Theriva Biologics?
Theriva Biologics all-time high annual total current assets is $68.86 M
What is Theriva Biologics annual current assets year-on-year change?
Over the past year, TOVX annual total current assets has changed by -$18.12 M (-39.80%)
What is Theriva Biologics quarterly total current assets?
The current quarterly current assets of TOVX is $19.53 M
What is the all time high quarterly current assets for Theriva Biologics?
Theriva Biologics all-time high quarterly total current assets is $78.64 M
What is Theriva Biologics quarterly current assets year-on-year change?
Over the past year, TOVX quarterly total current assets has changed by -$15.23 M (-43.82%)